Vitamin D does not improve cancer survival much – when dose size, etc. is ignored – Oct 2015

BMC Cancer 2015, 15:670 doi:10.1186/s12885-015-1684-0
Mona Jeffreys1, Maria Theresa Redaniel12 theresa.redaniel at bristol.ac.uk and Richard M. Martin134
1 School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK
2 NIHR CLAHRC West, 9th Floor, Whitefriars, Lewins Mead, Bristol BS1 2NT, UK
3 Medical Research Council/University of Bristol Integrated Epidemiology Unit, University of Bristol, Bristol, UK
4 University of Bristol/University Hospitals Bristol NHS Foundation Trust National Institute for Health Research Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, UK


This study appears to totally ignore

  • dose size
  • type of vitamin D (D2 vs D3)
  • if the person was taking any vitamin D not via prescription

Suspect that most of the prescriptions were for 2,000 IU of D2

There remains uncertainty in whether vitamin D status affects cancer survival. We investigated whether vitamin D (± calcium) supplementation affects cancer survival in women.

Participants were women aged ≥55 years identified from the UK Clinical Practice Research Datalink (CPRD) with a first diagnosis of breast, colorectal, lung, ovarian or uterine cancer between 2002 and 2009, and at least 5 years of CPRD data prior to diagnosis. Cox proportional hazards were used to estimate hazard ratios (HR) and 95 % confidence intervals (CI) of the relationship between pre-diagnostic vitamin D supplementation and all-cause mortality. To avoid confounding by indication, the primary analysis compared women with 3+ to 1–2 (but no more) vitamin D prescriptions. Models were adjusted for pre-diagnostic body mass index, smoking, alcohol and deprivation. A sensitivity analysis excluded supplements prescribed in the year prior to diagnosis.

Exposure to 3 or more versus 1 to 2 prescriptions of vitamin D was not associated with survival from any of the cancers studied. Any vitamin D prescription, compared to never having been prescribed one, was associated with a better survival from breast cancer (HR 0.78, 95 % CI 0.70 to 0.88). The sensitivity analysis suggested a possible detrimental effect of vitamin D supplementation on lung cancer outcomes (HR for 3 versus 1 or 2 prescriptions 1.22 (95 % CI 0.94 to 1.57); HR for any versus no prescriptions 1.09 (0.98 to 1.22)).

We found no evidence that vitamin D supplementation is associated with survival among women with cancer. Previous observational findings of beneficial effects of vitamin D supplementation on cancer survival may be confounded.

 Download the PDF from VitaminDWiki

List of attached files
ID Name desc uploaded Size Downloads Actions
6042 pdf Cancer survival.pdf PDF 2015 12 Oct., 2015 by admin 362.43 Kb 167 View Download  
See any problem with this page? Report it to the webmaster.